Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema

^aExecutive Vice President, Business and Product Development, Dyax Corp, 300 Technology Square, Cambridge, MA 02139

^bSenior Vice President, Development, Dyax Corp, 300 Technology Square, Cambridge, MA 02139